KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Arbutus Biopharma (ABUS) over the last 7 years, with Q3 2025 value amounting to $541000.0.

  • Arbutus Biopharma's Amortizatization of Intangibles fell 4496.44% to $541000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 67.11%. This contributed to the annual value of $3.1 million for FY2024, which is 4275.96% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Amortizatization of Intangibles of $541000.0 as of Q3 2025, which was down 4496.44% from $668000.0 recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Amortizatization of Intangibles ranged from a high of $983000.0 in Q3 2024 and a low of -$300000.0 during Q3 2021
  • Its 5-year average for Amortizatization of Intangibles is $332263.2, with a median of $534000.0 in 2023.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 805000.0% in 2021, then skyrocketed by 74337.35% in 2023.
  • Arbutus Biopharma's Amortizatization of Intangibles (Quarter) stood at -$246000.0 in 2021, then surged by 191.06% to $224000.0 in 2022, then surged by 176.34% to $619000.0 in 2023, then skyrocketed by 49.11% to $923000.0 in 2024, then tumbled by 41.39% to $541000.0 in 2025.
  • Its last three reported values are $541000.0 in Q3 2025, $668000.0 for Q2 2025, and $718000.0 during Q1 2025.